Skip to content

Corrigendum: Salvinorin A, a kappa-opioid receptor agonist hallucinogen: pharmacology and potential template for novel pharmacotherapeutic agents in neuropsychiatric disorders.

Eduardo R. Butelman, Mary Jeanne Kreek

Frontiers in pharmacology January 1, 2015 correction DOI: 10.3389/fphar.2015.00285 via PubMed

Study at a glance

Characteristics Correction notice
Topics Addiction Depression Salvia divinorum
Keywords Dynorphins Kappa-opioid receptor
Citations 3
Key finding The correction does not alter the review's scientific conclusions.

Abstract

In the original review, we placed an incorrect citation in a sentence. The correct sentence and citation are as follows: "Also, salvinorin A can act as a “punisher” to self-administration of cocaine or a short-acting MOPr agonist in primates (when given contingently; Freeman et al., 2014).” The authors apologize for the mistake. This error does not change the scientific conclusions of the review. References (Please Add)Freeman, K.B., Naylor, J.E., Prisinzano, T.E., Woolverton, W.L. (2014) Assessment of the kappa opioid agonist, salvinorin A, as a punisher of drug self-administration in monkeys. Psychopharmacology (Berl) 231, 2751-2758. doi:10.1007/s00213-014-3436-2

Explore topics

Comments

No comments yet.

Log in to comment